Literature DB >> 23760418

High gender -specific susceptibility to curare- a neuromuscular blocking agent.

Santosh K Maurya1, Muthu Periasamy, Naresh C Bal.   

Abstract

Curare, a selective skeletal muscle relaxant, has been used clinically to reduce shivering and as an anesthetic auxiliary in abdominal surgery. It is also widely used in animal experiments to block neuromuscular junction activity. Effective doses of curare diminish muscle contraction without affecting brain function, but at higher doses it is known to be lethal. However, the exact dose of curare initiating muscle relaxation vs. lethal effect has not been fully characterized in mice. In this study we carefully examined the dose-response for achieving muscle inactivity over lethality in both male and female mice (C57BL6/J). The most striking finding of this study is that female mice were highly susceptible to curare; both the ED₅₀ and LD₅₀ were at least 3-fold lower than male littermates. This study shows that gender-specific differences can be an important factor when administering skeletal muscle relaxants, particularly curare or other analogous agents targeted to the neuromuscular junction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760418      PMCID: PMC4854188          DOI: 10.4067/S0716-97602013000100011

Source DB:  PubMed          Journal:  Biol Res        ISSN: 0716-9760            Impact factor:   5.612


  15 in total

1.  A TORTURED PATH: Curare's journey from poison darts to paralysis by design.

Authors:  Rebecca Anderson
Journal:  Mol Interv       Date:  2010-10

2.  EEG should be performed during induced hypothermia.

Authors:  Anders Hovland; Erik Waage Nielsen; Jens Klüver; Rolf Salvesen
Journal:  Resuscitation       Date:  2005-12-01       Impact factor: 5.262

3.  The history of the introduction of curare into medicine.

Authors:  A E Bennett
Journal:  Anesth Analg       Date:  1968 Sep-Oct       Impact factor: 5.108

4.  Skeletal muscle histochemical and biochemical characteristics in sedentary male and female subjects.

Authors:  J A Simoneau; G Lortie; M R Boulay; M C Thibault; G Thériault; C Bouchard
Journal:  Can J Physiol Pharmacol       Date:  1985-01       Impact factor: 2.273

5.  Male and female differences in enzyme activities of energy metabolism in vastus lateralis muscle.

Authors:  H J Green; I G Fraser; D A Ranney
Journal:  J Neurol Sci       Date:  1984-09       Impact factor: 3.181

6.  Regional curare test in the study of neuromuscular transmission in hyperthyroidism.

Authors:  R Witoonpanich; A Vejjajiva; S Limpisvasti
Journal:  J Med Assoc Thai       Date:  1989-01

7.  Effect of ethanol, pentobarbital and morphine on the toxicity of hemicholinium-3 and d-tubocurarine in mice.

Authors:  J G Clement
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-11

8.  Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals.

Authors:  Naresh C Bal; Santosh K Maurya; Danesh H Sopariwala; Sanjaya K Sahoo; Subash C Gupta; Sana A Shaikh; Meghna Pant; Leslie A Rowland; Eric Bombardier; Sanjeewa A Goonasekera; A Russell Tupling; Jeffery D Molkentin; Muthu Periasamy
Journal:  Nat Med       Date:  2012-09-09       Impact factor: 53.440

9.  Dissociation of hyperthermic and hyperglycemic effects of central prostaglandin F2 alpha.

Authors:  K Nonogaki; A Iguchi; A Yatomi; K Uemura; H Miura; T Tamagawa; T Ishiguro; N Sakamoto
Journal:  Prostaglandins       Date:  1991-05

Review 10.  War and hunting poisons of the New World. Part 1. Notes on the early history of curare.

Authors:  N G Bisset
Journal:  J Ethnopharmacol       Date:  1992-02       Impact factor: 4.360

View more
  1 in total

1.  TIGAR deficiency enhances skeletal muscle thermogenesis by increasing neuromuscular junction cholinergic signaling.

Authors:  Yan Tang; Haihong Zong; Hyokjoon Kwon; Yunping Qiu; Jacob B Pessin; Licheng Wu; Katherine A Buddo; Ilya Boykov; Cameron A Schmidt; Chien-Te Lin; P Darrell Neufer; Gary J Schwartz; Irwin J Kurland; Jeffrey E Pessin
Journal:  Elife       Date:  2022-03-07       Impact factor: 8.140

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.